Kwaliteitsstandaard atypische parkinsonismen

Pagina 237 L ITERATUURLIJST MET VERWIJZINGEN 1. Kwaliteitsstandaarden, A.A.e.e. Leidraad voor Kwaliteitsstandaarden. . 2015. 2. Aerts, M.B., et al., Improving the diagnostic accuracy in parkinsonism: a three-pronged approach. Pract Neurol, 2012. 12 (2): p. 77-87. 3. Rizzo, G., et al., Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta- analysis. Neurology, 2016. 86 (6): p. 566-76. 4. Golbe, L.I., Progressive supranuclear palsy. Semin Neurol, 2014. 34 (2): p. 151-9. 5. Nath, U., et al., The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain, 2001. 124 (Pt 7): p. 1438-49. 6. Schrag, A., Y. Ben-Shlomo, and N.P. Quinn, Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet, 1999. 354 (9192): p. 1771-5. 7. Bower, J.H., et al., Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology, 1997. 49 (5): p. 1284-8. 8. Kawashima, M., et al., Prevalence of progressive supranuclear palsy in Yonago, Japan. Mov Disord, 2004. 19 (10): p. 1239-40. 9. Hou, C.E., et al., Frequency of dementia etiologies in four ethnic groups. Dement Geriatr Cogn Disord, 2006. 22 (1): p. 42-7. 10. Camuzat, A., et al., The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism. Mov Disord, 2008. 23 (16): p. 2384-91. 11. Clavaguera, F., et al., Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc Natl Acad Sci U S A, 2013. 110 (23): p. 9535-40. 12. Sanders, D.W., et al., Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron, 2014. 82 (6): p. 1271-88. 13. Narasimhan, S., et al., Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain. J Neurosci, 2017. 37 (47): p. 11406-11423. 14. Olfati, N., A. Shoeibi, and I. Litvan, Progress in the treatment of Parkinson-Plus syndromes. Parkinsonism Relat Disord, 2018. 15. Kalf, J.G., Orofaryngeale slikstoornissen bij de ziekte van Parkinson. Tijdschr Gerontol Geriatr, 2014. 45 (5): p. 282-9. 16. Koga, S. and D.W. Dickson, Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry, 2018. 89 (2): p. 175-184. 17. Staszewski J, P.-M.R., Brodacki B, Skrobowska E, Macek K, Stępień A., Vascular parkinsonism and vascular dementia are associated with an increased risk of vascular events or death. . Arch Med Sci Atheroscler Dis. , 2017. 2 (1): p. 16-23. 18. Nonnekes, J., et al., Freezing of gait: a practical approach to management. Lancet Neurol, 2015. 14 (7): p. 768-78. 19. Nieuwboer, A. and N. Giladi, Characterizing freezing of gait in Parkinson's disease: models of an episodic phenomenon. Mov Disord, 2013. 28 (11): p. 1509-19. 20. Tinazzi, M., et al., Pisa syndrome in Parkinson disease: An observational multicenter Italian study. Neurology, 2015. 85 (20): p. 1769-79. 21. McFarland, N.R., Diagnostic Approach to Atypical Parkinsonian Syndromes. Continuum (Minneap Minn), 2016. 22 (4 Movement Disorders): p. 1117-42. 22. van Rumund, A., et al., Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism. BMC Neurol, 2018. 18 (1): p. 69. 23. Postuma, R.B., et al., MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord, 2015. 30 (12): p. 1591-601. 24. Hughes, A.J., et al., The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain, 2002. 125 (Pt 4): p. 861-70. 25. Borm, C., et al., Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study. Parkinsonism Relat Disord, 2018.